Minggu, 25 Oktober 2026
iNarasikita — Mengubah Scroll Menjadi Senyuman
ıNarasikita23 Oktober 2026 · 1 hari lalu

Melanoma vaccine trial results 'phenomenal', researcher says

A world-first cancer vaccine has been shown to radically reduce the risk of melanoma recurrence and death. The results from an Australian-led phase 3 human trial revealed a 42 per cent reduction in the risk of melanoma recurrence. Melanoma Institute Australia medical director and principal investigator Georgina Long said the results were better than she had hoped. Note: In most cases, our captions are auto-generated.

Bagikan:WhatsAppFacebook

Video Lainnya

Semua video →